Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
Completed · Not applicable
Conditions studied: Neuropathy, Gastrointestinal Cancer
In brief
The purpose of this study is to evaluate the effects on strength, balance, and neuropathic symptoms (numbness, tingling, pain, weakness) of a 12 week, bi-weekly, 60 minute, group exercise program designed to improve lower extremity strength and balance with persons with oxaliplatin induced peripheral neuropathy.
Key facts
- Study ID
- NCT01422993
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 4
- Starts
- 2011-07-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2016-12-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Prior history of colon cancer
- Completed oxaliplatin based chemotherapy at least 6 months prior to enrollment
- Report numbness, tingling, or pain of the lower extremities ≥ 4 by chemotherapy induced peripheral neuropathy (CIPN) Visual Analog Rating
- Karnofsky performance status of at least 60%
- Able to read, write, and understand English
You may not qualify if…
- Patients will be excluded from the study if they live outside of a 30 mile radius of the University of South Florida, if they are currently undergoing chemotherapy or radiation therapy, or if they regularly (at least once a week) participate in strength or balance training exercises. The investigators will not exclude participants if they are participating in aerobic exercise, but we will collect that information so that the investigators may control for aerobic exercise in our data analysis.
Where it is running
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.